Talis Biomedical

$12.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+0.71%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell TLIS and other stocks, options, and ETFs commission-free!

About TLIS

Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.

CEO
Brian Coe
Employees
136
Headquarters
Menlo Park, California
Founded
2013
Market Cap
337.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
189.16K
High Today
$13.06
Low Today
$12.53
Open Price
$12.79
Volume
55.45K
52 Week High
$33.90
52 Week Low
$10.65

TLIS Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 18, Pre-Market

You May Also Like

FUJIY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure